Who
Deep Track Biotechnology Master Fund, Ltd.
10% owner
Company insider
Files Form 4 as: 10% owner, Attovia Therapeutics; 10% owner, LB Pharmaceuticals; 10% owner, Dynavax Technologies.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 6 Feb 2026
- Last trade
- 6 Aug 2026
- Last filed
- 10 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Aug 2026filed 10 Aug 2026 | ATTO Attovia TherapeuticsBiotechnology | SEC FORM 4 Code C | —1,957,138 | filing |
| 6 Aug 2026filed 10 Aug 2026 | ATTO Attovia Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —18,181,818 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | ATTO Attovia Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —18,181,818 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | ATTO Attovia TherapeuticsBiotechnology | SEC FORM 4 Code C | —1,957,138 | filing |
| 30 Jul 2026filed 3 Aug 2026 | LBRX LB Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code P | $10.0M286,205 at $34.94 | filing |
| 10 Feb 2026filed 11 Feb 2026 | Dynavax TechnologiesBiotechnology | SEC FORM 4 Code U | —15,726,349 | filing |
| 6 Feb 2026filed 10 Feb 2026 | LBRX LB Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code P | $8.0M378,444 at $21.17 | filing |
| 6 Feb 2026filed 10 Feb 2026 | LBRX LB Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code P | $2.0M93,925 at $21.17 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.